Q2 2026 Holdings
Filed 2026-08-14 | 20 holdings | $366.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $80.4M | 1,131,500 | 21.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $61.6M | 1,673,420 | 16.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $40.0M | 2,144,844 | 10.9% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $36.0M | 3,497,948 | 9.8% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $33.5M | 4,131,299 | 9.1% |
| Jade Biosceinces Inc(JBIO) | COM NEW | 008064206 | $21.9M | 986,760 | 6.0% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $19.1M | 643,381 | 5.2% |
| Karyopharm Therapeutics Inc(KPTI) | COMMON STOCK | 48576U205 | $14.8M | 1,518,113 | 4.0% |
| Onkure Therapeutics Inc(OKUR) | CLASS A COM | 68277Q105 | $12.9M | 2,839,674 | 3.5% |
| Helus Pharma Inc.(HELP) | COM STK | 23256X407 | $10.2M | 1,540,266 | 2.8% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.7M | 1,752,115 | 1.8% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $6.6M | 929,077 | 1.8% |
| Leonabio, Inc.(LONA) | COMMON STOCK | 04746L203 | $5.8M | 634,539 | 1.6% |
| Verastem Inc(VSTM) | COM | 92337C203 | $5.6M | 1,469,153 | 1.5% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $5.2M | 1,139,363 | 1.4% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $2.8M | 216,171 | 0.8% |
| Eugene Therapeutics(ENGN) | COM | 29286X101 | $2.2M | 1,271,257 | 0.6% |
| Jasper Therapeutics(JSPR) | COM | 471871202 | $604.0K | 1,438,159 | 0.2% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $447.6K | 108,126 | 0.1% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $926 | 1,425 | 0.0% |